Repligen (RGEN) Stock Insights
RGEN$182.70+6.90 +3.93%
$11.60B
Market Cap
-836.75
P/E
88.70
Forward P/E
45
Score
Repligen (RGEN) Stock Insights
RGEN price $182.70 +6.90 +3.93%
- Ticker
- RGEN
- Price
- $182.70
- Change
- +6.90 +3.93%
- Market cap ?
- $11.60B
- P/E ?
- -836.75
- Forward P/E ?
- 88.70
- Dividend yield ?
- 0.00%
- Beta ?
- 1.08
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Stocklytics score
- 45
- Value
- 28
- Quality
- 58
- Growth
- 48
Stocklytics score rationale: value 28, quality 58, growth 48.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 104541000 | 141236000 | 194032000 | 270245000 | 366260000 | 670534000 | 801536000 | 632362000 | 634439000 | 738256000 |
Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing. This encompasses…
Fair value
RGEN fair value $64.99. Price $182.70. Price is 181% above fair value.
Above fair value, and more expensive than usual. A larger premium than on 85% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 106.22M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.22% (beta 1.1). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 63.49M. Net debt 123.93M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2027-02-23 | — | 0.58 | — | 237.18M |
| 2026-10-27 | 0.53 | 0.46 | 209.31M | 206.70M |
| 2026-07-28 | 0.54 | 0.45 | 204.13M | 201.59M |
| 2026-05-05 | 0.48 | 0.38 | 194.25M | 192.05M |
| 2026-02-24 | 0.49 | 0.44 | 197.91M | 192.94M |
| 2025-10-28 | 0.46 | 0.42 | 188.81M | 182.13M |
| 2025-07-29 | 0.37 | 0.40 | 182.37M | 175.18M |
| 2025-04-29 | 0.39 | 0.35 | 169.17M | 163.69M |
| 2025-02-20 | 0.44 | 0.41 | 167.55M | 167.65M |
| 2024-11-12 | 0.43 | 0.34 | 154.87M | 153.02M |
| 2024-07-30 | 0.33 | 0.33 | 154.07M | 154.11M |
| 2024-05-01 | 0.28 | 0.29 | 151.35M | 150.06M |
| 2024-02-21 | 0.33 | 0.34 | 155.74M | 155.38M |
| 2023-10-31 | 0.23 | 0.14 | 141.19M | 140.69M |
| 2023-08-02 | 0.53 | 0.49 | 159.20M | 165.93M |
| 2023-05-02 | 0.64 | 0.59 | 182.66M | 181.42M |
| 2023-02-22 | 0.68 | 0.58 | 186.76M | 184.55M |
| 2022-11-01 | 0.77 | 0.68 | 200.74M | 191.50M |
| 2022-08-02 | 0.91 | 0.72 | 207.63M | 189.06M |
| 2022-04-27 | 0.92 | 0.72 | 206.40M | 185.48M |
| 2022-02-17 | 0.81 | 0.65 | 186.52M | 179.27M |
| 2021-10-28 | 0.78 | 0.64 | 178.22M | 163.97M |
| 2021-07-27 | 0.79 | 0.53 | 162.96M | 163.97M |
| 2021-05-04 | 0.68 | 0.43 | 142.84M | 117.87M |
| 2021-02-24 | 0.52 | 0.31 | 108.65M | 86.74M |
| 2020-11-05 | 0.40 | 0.28 | 94.06M | 65.84M |
| 2020-07-30 | 0.42 | 0.28 | 87.46M | 56.23M |
| 2020-05-06 | 0.32 | 0.22 | 76.09M | 49.93M |
| 2020-02-20 | 0.20 | 0.18 | 69.47M | 62.53M |
| 2019-10-31 | 0.26 | 0.20 | 69.44M | 50.75M |
| 2019-08-01 | 0.31 | 0.25 | 70.69M | 57.01M |
| 2019-05-09 | 0.28 | 0.21 | 60.63M | 45.48M |
| 2019-02-21 | 0.21 | 0.21 | 51.94M | 51.94M |
| 2018-11-01 | 0.20 | 0.18 | 49.53M | 44.58M |
| 2018-08-02 | 0.16 | 0.18 | 47.73M | 53.70M |
| 2018-05-08 | 0.17 | 0.15 | 44.83M | 39.56M |
| 2018-02-22 | 0.20 | 0.12 | 41.61M | 34.33M |
| 2017-11-09 | 0.15 | 0.11 | 36.58M | 26.82M |
| 2017-08-03 | 0.20 | 0.15 | 32.45M | 24.34M |
| 2017-05-04 | 0.15 | 0.13 | 30.59M | 26.51M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-06 | Douglass Brian Robb | Buy | 700 | — | — |
| 2026-10-06 | Douglass Brian Robb | Buy | 675 | $174.86 | 118.03K |
| 2026-10-05 | Loeillot Olivier | Buy | 4.20K | $154.96 | 651.14K |
| 2026-10-05 | Loeillot Olivier | Sell | 4.20K | $190.00 | 798.38K |
| 2026-10-05 | Loeillot Olivier | Sell | 1.33K | $178.75 | 238.27K |
| 2026-10-05 | Loeillot Olivier | Sell | 4.20K | $154.96 | 651.14K |
| 2026-10-02 | Loeillot Olivier | Sell | 1.25K | $181.70 | 226.76K |
| 2026-09-25 | Garland Jason K | Sell | 421 | $189.68 | 79.86K |
| 2026-09-24 | Loeillot Olivier | Buy | 8.40K | $154.96 | 1.30M |
| 2026-09-24 | Loeillot Olivier | Buy | 4.54K | $155.38 | 705.74K |
| 2026-09-24 | Loeillot Olivier | Sell | 4.54K | $190.00 | 862.98K |
| 2026-09-24 | Loeillot Olivier | Sell | 8.40K | $154.96 | 1.30M |
| 2026-09-24 | Loeillot Olivier | Sell | 4.54K | $155.38 | 705.74K |
| 2026-09-21 | Loeillot Olivier | Buy | 5.43K | $141.79 | 769.35K |
| 2026-09-21 | Loeillot Olivier | Sell | 5.43K | $180.00 | 976.68K |
| 2026-09-21 | Loeillot Olivier | Sell | 5.43K | $141.79 | 769.35K |
| 2026-09-04 | Loeillot Olivier | Sell | 3.04K | $165.90 | 503.51K |
| 2026-09-03 | Loeillot Olivier | Sell | 2.84K | $169.61 | 482.03K |
| 2026-09-01 | Hughes Violetta | Sell | 277 | $170.02 | 47.10K |
| 2026-08-20 | Loeillot Olivier | Buy | 5.43K | $141.79 | 769.35K |
| 2026-08-20 | Loeillot Olivier | Sell | 5.43K | $180.00 | 976.68K |
| 2026-08-20 | Loeillot Olivier | Sell | 5.43K | $141.79 | 769.35K |
| 2026-07-16 | Garland Jason K | Sell | 530 | $150.00 | 79.50K |
| 2026-06-25 | Garland Jason K | Sell | 733 | $145.00 | 106.28K |
| 2026-05-14 | Madaus Martin D | Buy | 995 | — | — |
| 2026-05-14 | Madaus Martin D | Buy | 2.24K | $103.38 | 231.47K |
| 2026-05-14 | Konstantinov Konstantin | Buy | 995 | — | — |
| 2026-05-14 | Konstantinov Konstantin | Buy | 2.24K | $103.38 | 231.47K |
| 2026-05-14 | EGLINTON MANNER CARRIE | Buy | 995 | — | — |
| 2026-05-14 | Mhatre Rohin | Buy | 995 | — | — |
| 2026-05-14 | Mhatre Rohin | Buy | 2.24K | $103.38 | 231.47K |
| 2026-05-14 | EGLINTON MANNER CARRIE | Buy | 2.24K | $103.38 | 231.47K |
| 2026-05-14 | Pax Margaret | Buy | 995 | — | — |
| 2026-05-14 | Pax Margaret | Buy | 2.24K | $103.38 | 231.47K |
| 2026-05-14 | DAWES KAREN A | Buy | 995 | — | — |
| 2026-05-14 | MUIR GLENN P | Buy | 995 | — | — |
| 2026-05-14 | MUIR GLENN P | Buy | 2.24K | $103.38 | 231.47K |
| 2026-05-14 | DAWES KAREN A | Buy | 2.24K | $103.38 | 231.47K |
| 2026-05-14 | BARTHELEMY NICOLAS | Buy | 995 | — | — |
| 2026-05-14 | BARTHELEMY NICOLAS | Buy | 2.24K | $103.38 | 231.47K |
| 2026-05-07 | MUIR GLENN P | Buy | 2.43K | $38.76 | 94.34K |
| 2026-05-07 | MUIR GLENN P | Buy | 2.43K | $38.76 | 94.34K |
| 2026-05-07 | Douglass Brian Robb | Sell | 334 | $126.43 | 42.23K |
| 2026-04-21 | Loeillot Olivier | Sell | 3.83K | $140.00 | 536.48K |
| 2026-03-05 | Hughes Violetta | Buy | 2.47K | — | — |
| 2026-03-05 | KURIYEL RALF | Buy | 5.28K | — | — |
| 2026-03-05 | KURIYEL RALF | Buy | 5.67K | $141.91 | 804.49K |
| 2026-03-05 | Loeillot Olivier | Buy | 24.13K | — | — |
| 2026-03-05 | Loeillot Olivier | Buy | 25.89K | $141.91 | 3.67M |
| 2026-03-05 | Bylund James | Buy | 7.75K | — | — |
| 2026-03-05 | Bylund James | Buy | 8.31K | $141.91 | 1.18M |
| 2026-03-05 | Garland Jason K | Buy | 7.75K | — | — |
| 2026-03-05 | Garland Jason K | Buy | 8.31K | $141.91 | 1.18M |
| 2026-03-04 | Bylund James | Buy | 125 | — | — |
| 2026-03-04 | Bylund James | Sell | 62 | $125.84 | 7.80K |
| 2026-03-04 | KURIYEL RALF | Buy | 125 | — | — |
| 2026-03-04 | KURIYEL RALF | Sell | 42 | $125.84 | 5.29K |
| 2026-03-02 | Bylund James | Sell | 2.43K | $124.97 | 304.05K |
| 2026-03-02 | Loeillot Olivier | Sell | 1.61K | $124.97 | 201.20K |
| 2026-03-02 | Hunt Anthony | Sell | 9.90K | $124.97 | 1.24M |
| 2026-03-02 | Garland Jason K | Sell | 715 | $124.97 | 89.35K |
| 2026-03-02 | KURIYEL RALF | Sell | 923 | $124.97 | 115.35K |
| 2026-03-02 | Douglass Brian Robb | Sell | 221 | $124.97 | 27.62K |
| 2026-02-27 | Bylund James | Sell | 1.48K | $128.73 | 190.26K |
| 2026-02-27 | Loeillot Olivier | Sell | 344 | $128.73 | 44.28K |
| 2026-02-27 | Garland Jason K | Sell | 327 | $128.73 | 42.09K |
| 2026-02-27 | KURIYEL RALF | Sell | 444 | $128.73 | 57.16K |
| 2025-12-31 | Douglass Brian Robb | Buy | 2.29K | — | — |
| 2025-12-31 | Douglass Brian Robb | Buy | 2.14K | $163.86 | 351.15K |
| 2025-12-31 | Douglass Brian Robb | Other | 0 | — | — |
| 2025-12-31 | Douglass Brian Robb | Other | 7.02K | $167.72 | 1.18M |
| 2025-12-17 | DAWES KAREN A | Sell | 275 | $161.00 | 44.27K |
| 2025-12-16 | MUIR GLENN P | Buy | 3.37K | $26.12 | 87.92K |
| 2025-12-16 | MUIR GLENN P | Buy | 3.37K | $26.12 | 87.92K |
| 2025-12-04 | Hunt Anthony | Sell | 2.00K | — | — |
| 2025-11-25 | Loeillot Olivier | Sell | 7.04K | $170.00 | 1.20M |
| 2025-11-18 | Bylund James | Sell | 2.19K | $151.21 | 331.30K |
| 2025-11-13 | Hunt Anthony | Sell | 1.78K | $151.01 | 269.40K |
| 2025-11-13 | Hunt Anthony | Sell | 2.10K | $152.17 | 319.56K |
| 2025-11-13 | Hunt Anthony | Sell | 2.92K | $153.14 | 447.63K |
| 2025-11-13 | Hunt Anthony | Sell | 2.50K | $154.32 | 385.80K |
| 2025-11-13 | Hunt Anthony | Sell | 3.00K | $155.45 | 466.35K |
| 2025-11-13 | Hunt Anthony | Buy | 2.95K | $33.87 | 99.98K |
| 2025-11-13 | Hunt Anthony | Sell | 5.74K | $156.22 | 896.23K |
| 2025-11-13 | Hunt Anthony | Sell | 1.96K | $157.11 | 307.31K |
| 2025-11-13 | Hunt Anthony | Buy | 2.95K | $33.87 | 99.98K |
| 2025-11-12 | Hunt Anthony | Sell | 25.00K | $33.87 | 846.75K |
| 2025-11-12 | Hunt Anthony | Buy | 25.00K | $33.87 | 846.75K |
| 2025-11-12 | Hunt Anthony | Sell | 3.74K | $154.92 | 579.56K |
| 2025-11-12 | Hunt Anthony | Sell | 4.74K | $155.85 | 738.73K |
| 2025-11-12 | Hunt Anthony | Sell | 4.96K | $156.65 | 776.83K |
| 2025-11-12 | Hunt Anthony | Sell | 11.10K | $158.01 | 1.75M |
| 2025-11-12 | Hunt Anthony | Sell | 464 | $158.51 | 73.55K |
| 2025-10-02 | Loeillot Olivier | Sell | 1.25K | $145.23 | 181.25K |
| 2025-09-25 | Garland Jason K | Sell | 412 | $121.68 | 50.13K |
| 2025-09-10 | Hunt Anthony | Sell | 20.00K | $33.87 | 677.40K |
| 2025-09-10 | Hunt Anthony | Buy | 20.00K | $33.87 | 677.40K |
| 2025-09-10 | Hunt Anthony | Sell | 96 | $116.34 | 11.17K |
| 2025-09-10 | Hunt Anthony | Sell | 1.11K | $118.32 | 131.10K |
| 2025-09-10 | Hunt Anthony | Sell | 3.26K | $119.64 | 390.27K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 497, holders +42 vs prior quarter. Ownership 118.04%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 5.38M | -608.12K | -10.15% | 734.72M |
| FMR LLC | 3.33M | 439.90K | +15.24% | 453.89M |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 2.79M | 16.67K | +0.60% | 380.76M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.41M | 14.66K | +0.61% | 328.98M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.31M | 7.73K | +0.34% | 315.56M |
| MAVERICK CAPITAL LTD | 1.98M | 465.75K | +30.67% | 270.77M |
| STATE STREET CORP | 1.80M | 23.25K | +1.31% | 245.68M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.75M | -3.13M | -64.08% | 239.08M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.62M | 219.51K | +15.71% | 220.61M |
| WASATCH ADVISORS LP | 1.59M | 346.72K | +27.88% | 216.97M |
| AMERIPRISE FINANCIAL INC | 1.58M | 650.92K | +70.35% | 215.05M |
| BANK OF NEW YORK MELLON CORP | 1.52M | -8.54K | -0.56% | 207.78M |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 1.41M | 44.94K | +3.29% | 192.60M |
| INVESCO LTD. | 1.39M | 108.99K | +8.53% | 189.28M |
| HOLOCENE ADVISORS, LP | 1.29M | 583.30K | +82.28% | 176.31M |
| RTW INVESTMENTS, LP | 1.24M | 34.64K | +2.87% | 169.27M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.06M | -1.98K | -0.19% | 145.00M |
| CONGRESS ASSET MANAGEMENT CO | 1.01M | 214.36K | +26.87% | 138.11M |
| CONESTOGA CAPITAL ADVISORS, LLC | 980.98K | -116.80K | -10.64% | 133.85M |
| GOLDMAN SACHS GROUP INC | 965.41K | 314.06K | +48.22% | 131.72M |
| DIMENSIONAL FUND ADVISORS LP | 949.86K | 95.12K | +11.13% | 129.60M |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 937.08K | 181.51K | +24.02% | 127.86M |
| FRANKLIN TEMPLETON INC | 890.22K | -302.92K | -25.39% | 121.46M |
| UBS GROUP AG | 795.01K | 124.68K | +18.60% | 108.47M |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 788.57K | 788.57K | New | 107.59M |
Insights
- Revenue by product
- Revenue by region
| Period | Value |
|---|---|
| FY2016 | Chromatography Products: 29520000.0, Filtration Products: 19774000.0, Other products: 431000.0, Protein Products: 54716000.0 |
| FY2017 | Chromatography Products: 36309000.0, Filtration Products: 49050000.0, Other products: 1761000.0, Protein Products: 53969000.0 |
| FY2018 | Chromatography Products: 45326000.0, Filtration Products: 90586000.0, Other products: 3604000.0, Protein Products: 54375000.0 |
| FY2019 | Chromatography Products: 64635000.0, Filtration Products: 119534000.0, Other products: 4399000.0, Process Analytics Products: 16405000.0, Product: 270097000.0, Proteins Products: 65124000.0 |
| FY2020 | Chromatography Products: 73551000.0, Filtration Products: 174896000.0, Other products: 3611000.0, Process Analytics Products: 33346000.0, Product: 366136000.0, Proteins Products: 80732000.0 |
| FY2021 | Chromatography Products: 91037000.0, Filtration Products: 403505000.0, Other products: 4051000.0, Process Analytics Products: 48019000.0, Product: 670319000.0, Proteins Products: 123707000.0 |
| FY2022 | Chromatography Products: 131680000.0, Filtration Products: 495930000.0, Other products: 5741000.0, Process Analytics Products: 53512000.0, Product: 801183000.0, Proteins Products: 114320000.0 |
| FY2023 | Chromatography Products: 126629000.0, Filtration Products: 347781000.0, Other products: 3688000.0, Process Analytics Products: 56820000.0, Product: 638381000.0, Proteins Products: 103463000.0 |
| FY2024 | Chromatography Products: 122810000.0, Filtration Products: 372963000.0, Other products: 4679000.0, Process Analytics Products: 59301000.0, Product: 634178000.0, Proteins Products: 74425000.0 |
| FY2025 | Chromatography Products: 153176000.0, Filtration Products: 402792000.0, Other products: 3320000.0, Process Analytics Products: 81237000.0, Product: 737960000.0, Proteins Products: 97435000.0 |
| Period | Value |
|---|---|
| Q1 2018 | All Other: 243000.0, Asia Pacific: 4947000.0, Europe: 19401000.0, North America: 20239000.0 |
| Q2 2018 | All Other: 55000.0, Asia and Australia: 5617000.0, Europe: 19578000.0, North America: 22481000.0 |
| Q3 2018 | All Other: 62000.0, Asia and Australia: 6075000.0, Europe: 19328000.0, North America: 24064000.0 |
Insights · Dividends · Forecast · Financials · Learn